Introduction
Intragastric balloons have been used for weight loss (WL) in the last two decades, but the need for hospital recovery, upper GI endoscopy, and anesthesia is major limitations for this technique. The Elipse™ intragastric balloon (EIGB) is a new swallowable balloon that has no such limitations and has been proven to be safe, effective in achieving weight loss is also, and well tolerated by patients [
1‐
6].
After EIGB placement, a standard low-calorie diet (LCD) program, based on a daily intake of about 1000–1200 kcal/day, is generally prescribed [
6]. The combination of the restrictive effect of EIGB and diet accounts for a significant loss of fatty free mass (FFM). Indeed, maintaining adequate FFM is an important consideration when making WL because muscles play a central role in whole-body protein metabolism [
7]. Additionally, a significant decrease in FFM may negatively affect the resting metabolic rate (RMR) [
8‐
11], slow the rate of WL, and predispose to weight regain [
12]. Moreover, no studies have been conducted so far on the amount of WL attributed to the loss of fat mass (FM) and FFM in the setting of EIGB treatment.
A low-calorie ketogenic diet (LCKD) has been proven to be safe and effective for WL [
13‐
17], especially in reducing FM while preserving FFM and RMR [
18‐
20].
Therefore, we designed a randomized controlled trial to compare the effect of LCKD and a standard LCD after EIGB on WL, FM, FFM, and RMR.
Discussion
Based on our findings, despite the small sample size, this study indicates that LCKD is associated with an increased FM loss while reducing the FFM loss and the RMR, without interfering with renal function after EIGB. These findings are in accordance with other studies who confirmed that the ketogenic diet is safe and highly effective in terms of BW reduction without inducing a significant FFM loss [
18,
34].
Interestingly, herein, we found that patients who followed the LCD had a greater total body weight loss, at 4 months after EIGB, than patients who followed the LCKD. Our findings indicate that the higher weight loss in the LCD group was mainly due to FFM loss and less FM than the experimental group. The net result of the body composition changes is a greater total body weight decrease in the LCD group. Our results indicate that the process of body weight loss is more physiologic in the experimental group that loses less FFM than the control group. Among the bioimpedance parameters measured with BIA, the phase angle (defined as the ratio of resistance (intracellular and extracellular resistance) to reactance (cell membrane-specific resistance) expressed as an angle) is a clinically important parameter used for nutritional assessment and for assessment of the risk of various disease [
35]. Interestingly, as shown in Table
3, herein, we found that patients who followed the LCD had a lower phase angle, at 4 months after EIGB placement, than patients who followed the LCKD. In our opinion, this finding is clinically relevant considering that the phase angle represents both the amount and quality of soft tissue, with a high phase angle reflecting higher cellularity, better cell heath and better nutritional status [
35].
Furthermore, the sustained weight and FM loss induced by LCKD did not induce any significant reduction in RMR, probably due to the preservation of FFM. In particular, we show that in the LCKD group, the RMR was preserved and remained within the expected limits for the variation in FFM. Interestingly, the metabolic adaptation phenomenon called “adaptative thermogenesis,” defined as a decrease in RMR out of proportion to the decrease in body mass was not activated in concomitance with the LCKD [
20,
36,
37]. On the contrary, patients in the LCD group in addition to the significant weight and FM loss showed a significant decrease in both FFM and RMR.
RMR is recognized as the major component of total energy expenditure, being responsible for about 75% of daily total energy expenditure [
38]. Therefore, any RMR reduction-induced WL translates into a large impact on energy balance, making subjects more prone to weight regain over time [
12,
20]. In agreement with Gomez-Arbelaez et al., herein, we found that the most plausible reason accounting for the not significant reduction of RMR seen in patients who had the LCKD after the EIGB is the preservation of FFM [
20]. Preservation of initial RMR after WL could play a key role in preventing weight regain in the short and long time [
39].
In the present study, we found that before EIGB placement, RMR was slightly but significantly higher in the LCKD group than that in the LCD group. However, this data is expected because despite the fact that it is widely accepted that FFM is the major factor determining RMR [
40], other factors, such as hormonal status and age, influence the RMR [
40].
LCKD appears to be protective against muscle mass catabolism for at least three reasons: first, low blood sugar’s level inhibits the muscle proteolysis; secondary, ketone bodies suppress the use of protein-derived amino acid by muscle; third, the β-hydroxybutyrate (the main ketone body produced during the ketogenesis process) promotes protein synthesis [
18,
41,
42].
We also found that patients were compliant with the diet protocol based on consistent weight loss and presence of ketonuria in accordance with other studies that attended weight loss with LCKD [
43‐
46].
Traditionally considered high protein, ketogenic diets are often looked at with concern by clinicians due to the potential harm they pose to renal function. Herein, as reported in a recent meta-analysis of Castellana et al [
47], we found that LCKD appears safe, considering that not only is it associated to an important improvement in patient’s clinical status but also does not affect renal function.
In the present study, body composition was measured by BIA. We are aware that BIA in severely obese patients has been criticized because of the altered electrical properties in body tissues, which may result in an overestimation of FFM and an underestimation of FM [
27,
28]. However, several studies conducted in patients with obesity validate the use of BIA for the measure of body composition [
25,
48‐
53]. Achamrah et al., in a retrospective study on 3655 subjects (653 males, 3002 females) with a body mass index (BMI) ranging from 16 to ≥ 40, found that values of FM and FFM obtained by BIA and DXA were strongly correlated (Pearson’s correlation,
r = 0.95,
p < 0.0001, and
r = 0.89,
p < 0.0001, respectively) [
48]. Furthermore, Faria et al. in a cross-sectional validation study with 73 patients invited to undergo a multi-frequency BIA and afterwards a DXA examination found an almost perfect correlation of FM and FFM (ICC = 0.832 and ICC = 0.899, respectively) [
51].
We acknowledge some methodological limitations of our study. First, despite after discharge the physical activity was encouraged, we were not able to directly measure it. Furthermore, FM and FFM were only measured by BIA and were not supplemented with additional and more accurate comparative measures, such as X-ray absorptiometry (DXA) or air displacement plethysmography (ADP) computed tomography (CT). However, Gomez-Arbelaez et al. recently assessed the LCKD-induced changes in body composition of patients with obesity by comparing DXA, BIA, and ADP to evaluate those changes [
19]. In this study, similarly to the present research, twenty obese patients followed a VLCK diet for 4 months. After 4 months, the VLCK diet induced a − 20.2 ± 4.5-kg weight loss, at expenses of reductions in fat mass (FM) of − 16.5 ± 5.1 kg (DXA), − 18.2 ± 5.8 kg (MF-BIA), and − 17.7 ± 9.9 kg (ADP). They conclude that a strong correlation was evidenced between the 3 methods of assessing body composition, and that of the 3 body composition techniques used, the MF-BIA method seems to be more convenient in the clinical setting [
19].
Nevertheless, DXA requires specialized radiology equipment and is expensive, and thus hardly feasible in routine clinical practice, whereas CT scan is not cost-effective and radiation exposure would not be acceptable for ethical issues. Therefore, despite the fact that we are aware that BIA, DXA, and CT scan methods cannot be considered interchangeable, if the systematic error associated to the measurements of BIA is accepted, the latter remains a simple, safe, non-invasive, and low-cost method for FM and FFM assessment in clinical practice and research studies also in the setting of obesity [
25,
48‐
53].
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.